Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03113175
Other study ID # Collabri Flex - Anxiety
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2018
Est. completion date March 29, 2021

Study information

Verified date February 2024
Source Mental Health Services in the Capital Region, Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study Collabri Flex is to: - Develop a Danish model for collaborative care for patients with anxiety in general practice, based on past experience gained in the Collabri Project. - Examine the impact of this model compared with liaison-consultation for people with anxiety in a randomized controlled design from selected endpoints.


Description:

The Collabri Flex model for Collaborative Care takes point of departure in the earlier study Collabri. It is changed according to gathered information under the first study of the Collabri model in order to achieve a Danish Collaborative Care model easier to implement. The aims of Project Collabri Flex are to: - Develop a flexible model for collaborative care (the Collabri Flex model) for patients with anxiety. - Study the effects of this Collabri Flex model against consultation liaison in a randomized design on selected outcomes. In Collabri the treatment is in line with a set of general treatment principles relevant for collaborative care interventions. The patients in the intervention group are offered cognitive behavioral therapy (CBT), psychoeducation and medication according to at stepped care model by a care manager refering to the general practitioner. The Collabri Flex study is set up as a researcher-blinded individually randomized controlled trial with participation of an intervention group (treatment according to the Collabri Flex model) and a consultation liaison group. This study will contribute with new knowledge on collaborative care interventions in a Scandinavian context.


Recruitment information / eligibility

Status Completed
Enrollment 302
Est. completion date March 29, 2021
Est. primary completion date March 29, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age: 18+ years - Danish speaking - Diagnosis of current anxiety in the form of panic disorder, generalized anxiety, PTSD, agoraphobia, OCD or social phobia based on the Mini International Neuropsychiatric Interview (MINI) by care manager that have been trained in using MINI. Patients can be referred from the GP on the basis of panic disorder, generalized anxiety, social phobia, OCD, PTSD, agoraphobia or depression diagnosis - The patient has given her/his written informed consent to participate in the trial at the described terms. Exclusion Criteria: - High risk of suicide assessed in the Mini International Neuropsychiatric Interview (MINI) and/or by the GP - Psychotic condition assessed in the MINI and/or by the GP - Patients with a diagnosis of dementia - Alcohol or substance misuse that will hinder the person's participation in Collabri treatment assessed by the practitioner or care manager at inclusion interview - If the patient has been referred or is recommended referral to secondary care treatment (mental health center) or psychiatrist in private practice - Patients who are assessed by the GP as medically unstable making it impossible for the patient to adhere to treatment - Bipolar affective disorder as assessed in the MINI and/or by the GP - Pregnancy For patients in the Collabri Flex group: - Patients with depression who wants treatment cf. the psychologist scheme (Psykologordningen) or similar treatment and do not want the refferal to the psychologist preceded by other treatment, cf. the Collabri Flex model assessed by the GP - Patients that wish to continue current psychological or psychiatric treatment due to anxiety or depression

Study Design


Intervention

Behavioral:
Collaborative care
Collaborative care provided by the general practitioner and the care manager. Treatment modalities: Cognitive-behavior Therapy, psychoeducation, medication according to a stepped care model
Consultations-Liaison
Consultation-Liaison provided by general practitioner involving a educational relationship with the Collabri Flex team (care manager and psychiatrist).

Locations

Country Name City State
Denmark Mental Health Centre Copenhagen Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Mental Health Services in the Capital Region, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Sick leave Obtained from the DREAM database 6 months
Other Sick leave Obtained from the DREAM database 18 months
Other Self-reported self-efficacy Measured by the IPQ-R Scale (Personal control) and two subscales from the Chronic disease Selv-Efficacy Scales (SECD-32); Obtain help from Community, Family, Friends Scale and control Manage Depression Scale 6 months
Other Self-reported self-efficacy Measured by the IPQ-R Scale (Personal control) and two subscales from the Chronic disease Selv-Efficacy Scales (SECD-32); Obtain help from Community, Family, Friends Scale and control Manage Depression Scale 18 months
Other Self-reported health-related quality of life Measured by EQ-5D 6 months
Other Self-reported health-related quality of life Measured by EQ-5D 18 months
Other Employment Obtained from the DREAM database 6 months
Other Employment Obtained from the DREAM database 18 months
Other Mental-health outpatient services National patient register 6 months
Other Mental-health outpatient services National patient register 18 months
Other Experience of support in recovery Self-reported support in recovery (INSPIRE) 6 months
Other Patient satisfaction Self-reported satisfaction with treatment (CSQ-8) 6 months
Other Self-reported degree of anxiety Measured by Beck Anxiety Inventory (BAI) 18 months
Other Self-reported degree of depression Measured by Beck Depression Inventory (BDI-II) 18 months
Other Self-reported pychological stress Measured by the Symptom Checklist SCL-90-R 18 months
Other Self-reported functional impairment Measured by Sheehan Disability Scale (SDS) 18 months
Other Self-reported quality of life/well-being Measured by WHO-5 18 months
Primary Self-reported degree of anxiety Measured by Beck Anxiety Inventory (BAI) 6 months
Secondary Self-reported degree of depression Measured by Beck Depression Inventory (BDI-II) 6 months
Secondary Self-reported pychological stress Measured by the Symptom Checklist SCL-90-R 6 months
Secondary Self-reported functional impairment Measured by Sheehan Disability Scale (SDS) 6 months
Secondary Self-reported quality of life/well-being Measured by WHO-5 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Recruiting NCT05934162 - Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD N/A
Recruiting NCT05934175 - Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder N/A
Completed NCT04460014 - Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT N/A
Recruiting NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Active, not recruiting NCT05992649 - The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject N/A
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Not yet recruiting NCT05331534 - Effect of Attentional Therapy on Post-traumatic Stress Disorder N/A
Not yet recruiting NCT03649607 - Accelerated Resolution Therapy for HIV Positive African, Caribbean and Black N/A
Not yet recruiting NCT04076215 - Biochemical and Physiological Response to Stressogenic Stimuli N/A
Not yet recruiting NCT02545192 - A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments Phase 1
Completed NCT02329418 - Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit N/A
Active, not recruiting NCT00978484 - A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder Phase 3
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT03278171 - Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
Recruiting NCT05874362 - People Bereaved by Violent Death : Negative Event Biases and Temporal Perception N/A
Terminated NCT03898843 - Assisted Animal Therapy: ReAnimal N/A
Recruiting NCT04747379 - Psychological Effect of Explicit Recall After Sedation (PEERS)
Completed NCT03248167 - Cannabidiol as a Treatment for AUD Comorbid With PTSD Phase 1/Phase 2